• Теги
    • избранные теги
    • Компании811
      • Показать ещё
      Разное207
      • Показать ещё
      Международные организации8
      • Показать ещё
      Страны / Регионы134
      • Показать ещё
      Показатели23
      • Показать ещё
      Люди25
      • Показать ещё
      Издания4
      Формат1
      Сферы1
Vertex Pharmaceuticals
21 июля, 21:46

Is a Beat in the Cards for Vertex (VRTX) in Q2 Earnings?

Impressive performance of Vertex Pharmaceuticals' (VRTX) cystic fibrosis drugs Kalydeco and Orkambi may drive the stock to an earnings beat in Q2.

21 июля, 18:23

What's in the Offing for Bristol-Myers (BMY) in Q2 Earnings?

Bristol-Myers Squibb Company (BMY) is scheduled to report first-quarter 2017 results on Jul 27, before the opening bell. Last quarter, the company beat earnings estimates by 16.7%.

21 июля, 16:46

Stock Market News for July 21, 2017

Deal between Sears and Amazon weighed on home improvement retailers on Thursday

21 июля, 16:30

Vertex Pharma, A10 Networks, Microsoft, Visa and eBay highlighted as Zacks Bull and Bear of the Day

Vertex Pharma, A10 Networks, Microsoft, Visa and eBay highlighted as Zacks Bull and Bear of the Day

21 июля, 15:52

Can Merck (MRK) Pull Off a Surprise this Earnings Season?

Merck & Co., Inc.'s (MRK) new products like Keytruda, Zepatier and Bridion are likely to drive sales in Q2. However, headwinds remain in the form genericization of key drugs and increasing competition.

21 июля, 15:20

Seres Therapeutics (MCRB) Catches Eye: Stock Gains 9.2%

Seres Therapeutics, Inc. (MCRB) shares rose a little above 9% in the last trading session.

21 июля, 14:01

Bull of the Day: Vertex Pharma (VRTX)

Bull of the Day: Vertex Pharma (VRTX)

21 июля, 01:15

U.S. Fund-Flows Weekly Report: Funds Suffer Net Outflows for the Fifth Week in Six

Thomson Reuters Lipper’s fund macro-groups (including both mutual funds and ETFs) experienced negative net flows of $272 million for the fund-flows week ended Wednesday, July 19. The net outflows were

20 июля, 17:43

Sarepta (SRPT) Q2 Loss Narrows, Ups Exondys 51 Sales View

Increase in Exondys 51 sales led Sarepta (SRPT) to post a narrower-than-expected loss in the second quarter of 2017.

20 июля, 15:30

Is Gilead (GILD) Poised for a Beat This Earnings Season?

Strong performance by HIV and other antiviral products is likely to drive Gilead Sciences Inc.'s (GILD) second-quarter 2017 results.

19 июля, 19:00

Here's Why Vertex Pharmaceuticals (VRTX) Soared Today

Shares of Vertex Pharmaceuticals Incorporated (VRTX) soared 24% in morning trading on Wednesday after the company released positive results for its cystic fibrosis treatments.

Выбор редакции
19 июля, 18:19

Vertex Shares Haven't Hit Their Apex

The ferocious rally in Vertex Pharmaceuticals shares on results in early stage data for its new cystic fibrosis treatment will surely tempt some investors to exit. That may not be wise, though, as the rally is likely to continue.

19 июля, 17:54

The Zacks Analyst Blog Highlights: Apple, JPMorgan, Celgene, PayPal and Vertex Pharmaceuticals

The Zacks Analyst Blog Highlights: Apple, JPMorgan, Celgene, PayPal and Vertex Pharmaceuticals

Выбор редакции
19 июля, 17:26

Vertex (VRTX) Triple Combination CF Studies Data Positive

Vertex announced positive data from three studies evaluating three different triple combination regimens. These demonstrated pronounced improvements in lung function in CF patients.

19 июля, 15:39

Biotech Stock Roundup: Vertex Boosted by CF Data, FDA Nod for Gilead, Puma Drugs

Vertex (VRTX) got a significant boost with positive data from its cystic fibrosis (CF) pipeline while quite a few companies provided regulatory updates.

Выбор редакции
19 июля, 15:00

Vertex Pharmaceuticals upgraded to outperform from market perform at Raymond James

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Выбор редакции
19 июля, 13:52

Vertex Pharmaceuticals stock fair value estimate set at $190 at Janney

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Выбор редакции
19 июля, 13:51

Vertex Pharmaceuticals upgraded to buy from neutral at Janney

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Выбор редакции
17 июля, 00:05

Eaton Vance fund managers see major upside for healthcare stocks -Barron's

The portfolio managers of the $1.2 billion Eaton Vance Worldwide Health Sciences fund are expecting big gains from a trio of healthcare stocks. Jason Kritzer and Samantha Pandolfi, co-managers of the fund, highlighted Vertex Pharmaceuticals, Zoetis and Shire for future outperformance in an article in Barron's. Pandolfi says she sees 15 percent upside for drugmaker Zoetis and 40 percent upside for Dublin-based drugmaker Shire.